Linical is a leading oncology CRO committed to ensuring a smooth journey in the development of your compound.

We optimize the timeline, conduct, budget, and quality of your oncology clinical study to maximize success.

A Leader in Oncology Clinical Trials

You require a partner that will reliably deliver and assist you in navigating the complexity of oncology clinical trial development and execution. From Phase I-IV, we have optimized our oncology service offering by dedicating staff, technology, and assets to provide you with reliable and transparent access to data to facilitate decision making. Our robust team member experience ensures exceptional execution in all development operations while offering flexible solutions to meet your specific needs. Linical is the dedicated partner you can count on before, during, and after your oncology clinical trial, as we share a common goal of helping your compound succeed.

Oncology Clinical Research Expertise You Can Count On

Linical offers experienced oncology project teams across the globe ready to support your next oncology clinical study. Expertise with your specific oncology indication is critically important when selecting the right partner for clinical trial conduct. Having completed hundreds of cancer clinical trials, our team is well positioned to leverage their experience to advance your development. Oncology is complex; each indication has its own nuances and challenges to surmount, and selecting the right oncology CRO for your next study requires a partner that can provide focus and dedication to you and your team. We have worked on cancer studies with a diverse range of patient populations and have built a strong network of investigator sites to support these trials. Explore more of Linical's oncology CRO specialities below.


Oncology, Specialties

The Linical team has years of experience in traditional therapies, as well as the promising new therapeutic classes including immunotherapies and cell and gene therapies. We are also well-versed in different combination therapies, oncology vaccines, pediatric, and rare cancers.

Solid Tumors

Linical excels in solid tumor clinical trials, spanning many types of cancer. With 20+ years of experience running oncology studies, we have therapeutically aligned project teams that add value to your trial every step of the way.

Our solid tumor oncology experience includes Phase I-IV clinical trials across the globe, in key indications such as:

  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colon Cancer
  • Gastric Cancer
  • Gynecological Cancer
  • Liver Cancer
  • Lung Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Skin Cancer

Liquid Tumors

Linical has experience conducting hematology clinical trials across the globe in a variety of indications and patient populations.

Our hematology CRO experience encompasses many types of liquid tumors and hematological malignancies including:

  • Leukemia
  • Lymphoma
  • Other blood cancers and conditions

Immunotherapies and Rare Cancer

The oncology research field is getting more competitive and trial designs are increasing in complexity. The pace of novel ideas continues to accelerate with rapid advancements in technology, science, and medicine. With Linical’s strong expertise in immunotherapies and advanced trial design, complex studies are made easy.

More frequently, cancer therapies are targeting small subsets of patients with rare mutations or patients that have been treated with a very specific therapeutic regimen. Linical has experience supporting many types of cancer therapies and programs of varying complexity, including:

  • Cell and Gene Therapies
  • Cellular Immunotherapies
  • Adaptive Trials
  • Targeted Therapy
  • Radiotherapy
  • Chemotherapy and Supportive Care
  • Hormonal Therapy
  • Oncolytic Viruses
  • Peptide Vaccines
  • Bispecific T-Cell Engagers
  • Immune Checkpoint Inhibitor (ICI)
  • Advanced Therapy Medicinal Products (ATMP)
  • Adoptive T-Cell Therapies (Autologous & Allogeneic)
  • Master Protocols (Including Basket & Umbrella Trials)

Early Phase Oncology

Linical also differentiates itself from other oncology CROs by excelling in early phase oncology clinical research (Phase I-II). Our unique early phase oncology solutions enable rapid study start up, drive operational efficiency, and get you to key inflection points faster.

  • Long term partners offering ease of doing business, including contracting, proactive problem solving, and access to management for governance meetings
  • The right size including attentive project teams and global country coverage
  • Lean management allowing us to offer competitive rates, reactivity, and faster start up

“We love working with Linical across our development programs. They have been a true partner that collaborates effectively with our team and aligns with our goals.”

Chief Medical Officer

mid-sized biopharmaceutical company

Linical’s Oncology Expertise in Numbers


Repeat Business Rate

Clients value Linical’s flexible and strategic approach to oncology trials, and >85% of Linical’s clients return to us for their next study.


Studies in Early Phase Oncology

Did you know 50% of Linical’s oncology experience is in early phase oncology? Our unique solutions from Phase I-II trials enable rapid study start up, drive operational efficiency, and get you to key inflection points faster.

Studies in Rare Cancer

Linical excels at complex trials, and more than 20% of our oncology experience is with rare cancers. We understand the special demands of these trials and provide innovative solutions to succeed.

A Personalized Approach to Oncology Clinical Development

For Linical, oncology clinical research is personal, and many of our team members have dedicated their entire careers to oncology research or clinical care. This means our project teams are deeply knowledgeable of the complexities of oncology trials and passionate about overcoming challenges. We understand the importance of your trial and the impact it can have on patients across the globe. Our dedicated oncology project teams roll over from study to study together, giving your trial continuity and our undivided attention.

Full-Service Oncology CRO Services

Full-Service Oncology CRO Services

We have proven experience expertly navigating all stages of oncology clinical development, from trial planning to study conduct and product launch. Our full range of oncology CRO services even includes rescue studies, and clients love Linical’s innovative approaches to even the most challenges indications.

Local Area Expertise, Global Reach

Local Area Expertise, Global Reach

Linical has team members across the world in all key clinical development regions, including North America, Europe, and Asia-Pacific. Our team members are well-versed with the nuances of oncology studies in various geographic areas, meaning wherever in the world your trial takes you, we are there. We work collaboratively with clients, subject matter experts, and sites to set your program up for success.

Powerful Site Relationships

Powerful Site Relationships

Linical works with the industry’s best oncology sites and subject matter experts to get you the right patients for your trial. From years of conducting oncology studies across the globe, our medical experts and project teams have formed strong site relationships. These relationships add value to your program every step of the way, including knowledge of the competitive landscape, indication-specific challenges, and strategies for success.

Patient-centric Approaches

Patient-centric Approaches

Every detail matters to Linical, from the recruitment plan to every SAE. Why? The real goal and endpoint is the patient in our complex oncology drug development industry. We work collaboratively with subject matter experts and indication-focused research centers to understand the special needs of cancer patients and formulate a plan for your trial that actually works for patients.

Explore Linical’s Oncology CRO Services


Drug Development Strategy

Drug Development Strategy

Linical provides comprehensive solutions for drug development strategy, including regulatory affairs, protocol development and study design, medical writing, and quality assurance.Through assessing scientific, regulatory, and commercial considerations, Linical works in collaboration with clients to optimize your trial’s drug development strategy.

Clinical Trial Management

Clinical Trial Management

Linical’s comprehensive clinical trial management services are designed to help your program achieve high-quality data, on time and on budget. From study start up and feasibility, to project management, biometrics, and drug safety, Linical has the flexibility and experience you need.

Successful clinical trials start with Linical.

Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals. 

01 Request a proposal

We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.

02 Get a plan for success

We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.

03 Execute with confidence

We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.

cta-img (2)